1. Home
  2. CREV vs TSBX Comparison

CREV vs TSBX Comparison

Compare CREV & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREV
  • TSBX
  • Stock Information
  • Founded
  • CREV 2007
  • TSBX 2015
  • Country
  • CREV Ireland
  • TSBX United States
  • Employees
  • CREV N/A
  • TSBX N/A
  • Industry
  • CREV
  • TSBX
  • Sector
  • CREV
  • TSBX
  • Exchange
  • CREV Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • CREV 7.2M
  • TSBX 8.4M
  • IPO Year
  • CREV N/A
  • TSBX 2023
  • Fundamental
  • Price
  • CREV $3.06
  • TSBX $0.35
  • Analyst Decision
  • CREV
  • TSBX Buy
  • Analyst Count
  • CREV 0
  • TSBX 3
  • Target Price
  • CREV N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • CREV 31.5K
  • TSBX 102.4K
  • Earning Date
  • CREV 01-01-0001
  • TSBX 05-12-2025
  • Dividend Yield
  • CREV N/A
  • TSBX N/A
  • EPS Growth
  • CREV N/A
  • TSBX N/A
  • EPS
  • CREV N/A
  • TSBX N/A
  • Revenue
  • CREV $39,261,077.00
  • TSBX N/A
  • Revenue This Year
  • CREV $40.76
  • TSBX N/A
  • Revenue Next Year
  • CREV $86.18
  • TSBX N/A
  • P/E Ratio
  • CREV N/A
  • TSBX N/A
  • Revenue Growth
  • CREV 41.52
  • TSBX N/A
  • 52 Week Low
  • CREV $2.00
  • TSBX $0.29
  • 52 Week High
  • CREV $14.55
  • TSBX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • CREV 52.62
  • TSBX 45.71
  • Support Level
  • CREV $2.80
  • TSBX $0.29
  • Resistance Level
  • CREV $3.45
  • TSBX $0.41
  • Average True Range (ATR)
  • CREV 0.35
  • TSBX 0.04
  • MACD
  • CREV 0.05
  • TSBX -0.00
  • Stochastic Oscillator
  • CREV 70.27
  • TSBX 48.39

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: